Cyclic lipid derivatives as potent PAF antagonists

Details Cyclic lipid derivatives as potent PAF antagonists Cyclic lipid derivatives as potent PAF antagonists

1995-06-07

1997-03-11

Ivy, C. Warren

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

5462681, 546 22, 5462797, 546339, C07D21320, A61K 3144

Patent

active

056103107

ABSTRACT:
The present invention describes novel cyclic diol derivatives represented by formula I and II: ##STR1## in which Y represents O, S, SO, SO.sub.2, (CH.sub.2).sub.m wherein m is zero or an integer of 1 to 5, or NR.sup.a group wherein R.sup.a is hydrogen, lower alkyl, lower alkoxycarbonyl, aryl, arylalkyl or acyl;

REFERENCES:
patent: 4429162 (1984-01-01), Cooke
patent: 4665197 (1987-05-01), de Nie-Sarink et al.
patent: 4701534 (1987-10-01), Mason et al.
patent: 4797411 (1989-01-01), Crugnola
patent: 4851450 (1989-07-01), Demopoulos
patent: 4891363 (1990-01-01), Nakamura et al.
patent: 4940706 (1990-07-01), Bartoli et al.
patent: 4945098 (1990-07-01), Grue-Sorensen et al.
patent: 4987132 (1991-01-01), Mase et al.
patent: 4997843 (1991-03-01), Carceller et al.
patent: 5004569 (1991-04-01), Meier et al.
patent: 5047420 (1991-09-01), Graham et al.
Houlihan, William, Journal of Lipid Mediators, vol. 3, pp. 91-99, 1991.
Chemical Abstracts, vol. 114, No. 19 (1991), Tsushima et al., "Preparation of pyridinium compounds as platelet-activating factor (PAF) antagonists", p. 769, Col. 1.
Chemical Abstracts, vol. 116, No. 13, (1992), Kertscher et al., "PAF antagonists with phospholipid structure. Part 2: Phospholipids with heteroarene head groups and increased phosphorus nitrogen distance; synthesis, characterization and structure-activity relationships", p. 946, Col. 2.
Chemical Abstracts, vol. 116, No. 1 (1992), Okano et al., "Preparation of cyclohexanediol derivatives as platelet-activating factor (PAF) antagonists", p. 613, Col. 1.
Matyas Koltai et al., "Platelet Activating Factor (PAF) A Review of its Effects . . . (Part I)", Drugs 42(1) (1991), pp. 9-29.
Matyas Koltai et al., "PAF A Review of Its Effects . . . (Part II)", Drugs 42 (2) (1991), pp. 174-204.
Michael C. Venuti, "Platelet Activating Factor Receptors", Comprehensive Med. Chem., vol. 3 (1990) pp. 715-761.
Kelvin Cooper et al., "SAR of PAF Antagonists", Annual Reports in Medicinal Chemistry, vol. 24, Chapter 9 (1989), pp. 81-90.
CA 73 : 87792 Beiezin 1970.
The Journal of Experimental Medicine, vol. 136 (1972), Jaques Benveniste et al., "Leukocyte-Dependent Histamine Release From Rabbit Platelets", pp. 1356-1377.
CA 107 : 39243 Gautam et al. 1986.
Chemical Abstracts, vol. 116, No. 13 (1992), Kertscher et al., "PAF antagonists with phospholipid structure. Part 1: Phospholipids with heteroarene head groups; synthesis, characterization and activity-determining structural requirements", p. 946, Col. 2.

Affiliated with

Also associated with

Rating

Cyclic lipid derivatives as potent PAF antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic lipid derivatives as potent PAF antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic lipid derivatives as potent PAF antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-444734